Found 89 investors
NextPhase Technology Ventures
United States
Founded in 2020, NextPhase Technology Ventures is a venture capital firm based in Cupertino, California. The firm provides integrative venture capital and private equity solutions to start-ups and established companies requiring intellectual property productization and realization services. The firm focuses on technology sector.
Venture Capital
Nicholas Ancerl
United States
Dr. L. Andrew Tseng is an Angel Investor. He served as Associate, Intellectual Property Department at Pepper Hamilton. He focuses his practice on patent matters.
Individual/Angel
Northstack
United States
Mr. David Bolliger serves as Angel Investor. Mr. David Bolliger served as General Partner, Australia & Asia at InterValley Ventures. Mr. Bolliger was the Chief Executive Officer and a Founder of Tilefile. In his first venture with Japan, David Bolliger raised more than USD 12 million investment including from Netage (Tokyo) and Motorola Ventures (Chicago). The venture developed an iPhone-like experience called TileFile, before the iPhone existed. David is an entrepreneurial creative who has completed projects in Australia, Switzerland, Japan, the USA, Taiwan, Thailand and the Philippines. Trained by several brilliant psychologists, such as Drs Hal and Sidra Stone in California, David has 30 years experience mentoring and counselling. He has been private advisor to high profile executives and has been trouble shooter for numerous teams. David designed and produced a surgical device and an iPad accessory, and has sold various intellectual property. He is skilled in both written and visual storytelling, in intellectual property, trademarks and brand. His wide ranging professional life gives him valuable insight into the innovation journey and what types of teams succeed.
Individual/Angel
NTUitive
Singapore
NTUitive is an accelerator program which is responsible for managing the intellectual property assets of The Nanyang Technological University and to take technology from the laboratory to the marketplace. It is based in Singapore, Singapore and seeks to invest in the technology startup companies. It provides the startups with mentorship, working space and early stage funding.
Accelerator
Incubator
Padraic Gilligan
United States
Mr. Gérard Leduc is an Angel Investor. Mr. Gérard Leduc served as President & Chief Executive Officer at Ethypharm. After beginning his career as Head of Intellectual Property at the European Institute for Research and medical applications, and then created his own firm PSI Industrial Property, he co-founded and directs Ethypharm from 1977. He became the Chairman and Chief Executive Officer from 1981 until 2007. It remains to this day President and Director of Shanghai Ethypharm subsidiaries. Gérard Leduc graduated from the Ecole Nationale Supérieure de Chimie de Strasbourg, the Centre for International Intellectual Property Studies of Strasbourg and the Institute of International Commerce in Paris. He is a director of various companies including the industry valuation of the Institut Gustave Roussy (IGR & D) in Villejuif.
Individual/Angel
Pavitar Singh
United States
Dr. Joan Fallon is the Founder & serves as Chief Executive Officer at Curemark. Having filed her first patent application in 1999, Dr. Fallon has worked to research autism and related disorders as well as to bring her findings to a platform for commercialization. Dr. Fallon has both clinical and academic experience. As a seasoned clinician, she worked as a pediatric chiropractor for 25 years specializing in pediatric development. She taught anatomy, physiology, and developmental biology as an assistant professor of natural science and mathematics at Yeshiva University, in addition to lecturing about pediatric development around the world. Dr. Fallon served on the advisory board for Oxford health plans, as well as on the boards of numerous not for profits. Dr. Fallon's discovery of the biomarker for autism and ADHD and her vast array of the intellectual property in the area of gastrointestinal secretory deficiencies, forms the basis of Curemark. She served as an advisor to the New York Yankees for disability services for the new Yankee Stadium. She has a BA degree from Franklin and Marshall College, a DC degree from Palmer University, and has completed her work for the MSc in clinical investigation from Harvard University's joint program with Massachusetts General Hospital. She resides in Bronxville, NY.
Individual/Angel
Pendrell Corporation
Kirkland, Washington, United States
Pendrell Corporation, through its wholly-owned subsidiary, Pendrell Technologies, Inc., provides corporate intellectual property solutions
Enterprise Software
Information Technology
Intellectual Property
Telecommunications
Wireless
Corporate Venture Capital
Platform Ventures
United States
Founded in 2018, Platform Ventures is a venture capital firm based in Darien, Connecticut. The firm seeks to invest in early stage companies operating in enterprise & consumer technology, consumer products, financial services, intellectual property, and media sectors.
Venture Capital
Powerhouse Ventures
Christchurch, Canterbury, New Zealand
powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures
Financial Services
Intellectual Property
Venture Capital
Micro VC
Venture Capital
Raj Parekh
United States
Mr. Patrick Perrin serves as Partner at Berg Hill Greenleaf & Ruscitti. He served as Deal Structure & Corporate Attorney at Crecendo Capital Partners. He focuses on intellectual property protection and related business transactions. He represents startups, emerging companies and established public companies, including software and hardware developers, service providers, vendors, resellers and manufacturers. Patrick advises clients on each step of the process of developing, managing, protecting and commercializing intellectual property. Along with protecting trade secret information, trademarks and copyrights, structuring and negotiating license agreements, development agreements and other transactions, his work includes financing and operations, strategic development and alliances, supply and distribution, marketing and advertising. Patrick handles mergers and acquisitions, financing, and real estate transactions. His expertise complements BHGR's corporate law group with over 20 years of Colorado experience. After graduating first in his class from law school, Patrick served as a law clerk to The Honorable Robert McWilliams, U.S. Court of Appeals for the Tenth Circuit. He started his career at Holme Roberts & Owen as an associate from 1991 to 1997 and a partner from 1997 to 1999 in Boulder. Patrick then helped found the Boulder office of the international law firm of Hogan Lovells, serving as partner from 1999 to 2010. He joined BHGR in January, 2011. Patrick was formerly a professional tennis player. He earned a Black Belt in Tae Kwon Do and Brazilian Jiu-Jitsu. He originally moved to Colorado to attend law school and to pursue his outdoor interests which he still enjoys with his family.
Individual/Angel
Regal Partners
United States
Regal Partners was both an investor group and professional consulting firm with specialized expertise on private equity, valuation, investment banking, as well as mergers and acquisitions. The firm used to invest in companies operating in energy, agriculture, utilities, construction, manufacturing, aerospace, defense, beverages, consumer, industrial, information technology, intellectual property, real estate, financial, retail, media and services. It was founded in 2006 and was based in Miami, Florida.
Private Equity Firm
Richard Campione
United States
Mr. Kilb serves as the President and Chief Executive Officer at N2 Global Solutions. He joined N2 Global Solutions in June, 2014 following 22 years at Bloomberg LP, including more than 15 years as General Counsel. Karl built and managed a global legal department and worked on all aspects of Bloomberg's data, network, software, hardware, electronic trading and multimedia businesses, including strategic planning, risk management and business development. Karl was a founding principal of Bloomberg Tradebook LLC, an electronic agency broker. Karl regularly speaks on intellectual property and other legal issues, as well as business development. Before becoming a lawyer, Karl was a broadcast journalist with 1010 WINS Radio, CNBC, and Bloomberg. Karl is involved with a number of charities, including the Board of Trustees of the Madison Square Boys & Girls Club.
Individual/Angel
Sanford T. Colb & Co. Advocates and Patent Attorneys
Rehovot, HaMerkaz, Israel
Sanford T. Colb & Co. is a full-service intellectual property and technology law firm.
Venture Capital
Venture Capital
SATT Paris-Saclay
France
SATT Paris-Saclay is an accelerator that is based in Paris, France. The two main activities of the firm are the investment in intellectual property and the realization of maturation projects based on the innovations of the laboratories of the future Paris-Saclay University. The major objective is to increase the level of maturity of the technologies in order to favor the transfer of technology towards the industry or the creation of companies.
Accelerator
Incubator
Silicon Ventures
United States
Silicon Ventures was a venture capital firm that used to invest in the new semiconductor and intellectual property start-up companies. The firm was based in Los Altos, California.
Venture Capital
Singularity Ventures (Malaysia)
Malaysia
Founded in 2007, Singularity Ventures is a venture capital firm based in Kuala Lumpur, Malaysia. The firm seeks to invest in firms that have high potential in technology innovation, intellectual property, and market inflection points. The firm's current investments are in the space of semiconductors, neuromorphic chips, genomics, and knowledge management.
Venture Capital
SINTEF Venture AS
Trondheim, Sor-Trondelag, Norway
SINTEF TTO & Venture manages intellectual property and venture capital funds on behalf of SINTEF.
Innovation Management
Venture Capital
Venture Capital
StartHub Wageningen
United States
Mr. Michael Francis serves as Angel Investor at Michael Francis. Mr. Michael Francis served as the Chief Global Brand Officer at DreamWorks Animation SKG. In this role, Francis is responsible for the Company's worldwide branding initiatives, including the branding of all of the intellectual property associated with the studio. Additionally, he is responsible for licensing and consumer products efforts as well as franchise management activities. Francis previously served as Chief Executive Officer and Founder of Farview Associates, LLC, a global brand agency representing a diverse slate of retail, design and celebrity partners. Prior to this, he was President of J.C. Penney, where he oversaw marketing, merchandising, design and global sourcing. Prior to J.C. Penney, Francis spent more than 26 years with the Target Corporation, ultimately serving as Executive Vice President and Chief Marketing Officer. He was responsible for all marketing, communications and advertising operations. Francis serves on the National Board of the Smithsonian Institution, St. Jude Children's Research Hospital, and Cooper-Hewitt National Design Museum. He is also a member of the board of directors of the investment bank Piper Jaffray Companies. Francis graduated from the University of Michigan with a BA in International Studies.
Individual/Angel
Susan Athey
United States
Dr. Ian Garner co-founded and served as Chief Scientific Officer and Board Member at ProFactor Pharma. Ian graduated with a BSc Hons in Genetics from Leeds University followed by a PhD in Molecular Biology at the University of Edinburgh. From 1977-79 he worked on the first use of genetic engineering in an industrial process whilst at ICI. The postdoctoral experience was gained at the Pasteur Institute in Paris following which, he returned to the UK to work in the UK Biotechnology sector. Ian worked with Delta Biotechnology (Nottingham) 1988-90, is responsible for the expression of rFVIII in the milk of transgenic livestock and mammalian cells in vitro. In 1990; he joined PPL Therapeutics as Assistant Director of Research, where he further developed this technology in Scotland and the USA. During his 9 years with the company, Ian performed a range of functions including Research Management and Product Discovery and had significant exposure to Business Development and Intellectual Property Management. Ian has overseen the production of over 30 recombinant proteins including five protein members of the blood coagulation cascade. Ian joined Stem Cell Sciences UK as Chief Operating Officer in 2000, establishing the company's UK base in Edinburgh. In 2003, Ian was appointed CEO at NCIMB Ltd, Aberdeen, and led them to the verge of a public listing. Since 2005, Ian has been operating as an independent consultant to the Life Sciences Sector in the UK and Europe.
Individual/Angel
The Caedmon Group
United States
Founded in 2000, The Caedmon Group is a ventures capital firm based in New York, New York with an additional office in London, United Kingdom. The firm provides investment opportunities in the areas of hedge funds, venture capital, private equity, and intellectual property in the United States and Europe.
Venture Capital
Showing 61 to
80 of
89 results